Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES INC | 07-23-2024 | 06-30-2024 | 21997 | 1,598,014,674 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ANAPTYSBIO INC | COM | 18801 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 06-30-2024 |
AMYLYX PHARMACEUTICALS INC | COM | 18802 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 06-30-2024 |
AMREP CORP | COM | 18803 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 06-30-2024 |
AMPIO PHARMACEUTICALS INC | COM | Liquidated | $0 | 0 | 0.00 | 0 | NaN | 06-30-2024 |